Evidence map›Paper›PMID 32232734›Full record

ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2021

Exploring Medication Adherence with P2Y

Kangho Suh, Anirban Basu, Josh J Carlson, Kelley R Branch

Abstract read
PubMed Publisher
In one paragraph

Article in American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kangho SuhDepartment of Pharmacy and Therapeutics, University of Pittsburgh, 5607 Baum Blvd Room 303, Pittsburgh, PA, 15206, USA. Kas551@pitt.edu.ORCID http://orcid.org/0000-0002-7906-9398
Anirban BasuThe Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0003-4238-7402
Josh J CarlsonThe Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0001-7664-8370
Kelley R BranchDivision of Cardiology, University of Washington, Seattle, WA, 98195, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious research assessing medication adherence with P2Y METHODS AND

resultsThis study used the commercial claims and encounters databases from IBM

conclusionsUsing CQR and UQR allowed for heterogenous assessment of covariates along the adherence distribution, which is not possible with the traditional logistic regression method. The UQR framework revealed patients who initiate prasugrel or ticagrelor generally have lower adherence compared to those treated with branded clopidogrel, especially around the 30th quantile. Using these methods in other types of data sets, such as electronic health records, could help strengthen our results to develop policies to improve antiplatelet adherence in a targeted population.

Indexed as

Drug MonitoringClopidogrelComorbidityDrugs, GenericFemaleHumansInsurance Claim ReviewLogistic ModelsMaleMiddle AgedPatient Acceptance of Health CarePlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsResidence CharacteristicsRetrospective StudiesClopidogrelDrugs, GenericPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagrelor

Identifiers

PMID32232734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.